Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS, Chaudhari A, Kulkarni PS, Borrow R, Findlow H, Brown V, McDonough ML, Dally L, Alderson MR.

Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14.

PMID:
30120069
2.

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator.

Sow SO, Tapia MD, Chen WH, Haidara FC, Kotloff KL, Pasetti MF, Blackwelder WC, Traoré A, Tamboura B, Doumbia M, Diallo F, Coulibaly F, Onwuchekwa U, Kodio M, Tennant SM, Reymann M, Lam DF, Gurwith M, Lock M, Yonker T, Smith J, Simon JK, Levine MM.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00265-17. doi: 10.1128/CVI.00265-17. Print 2017 Dec.

3.

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.

Sears KT, Tennant SM, Reymann MK, Simon R, Konstantopoulos N, Blackwelder WC, Barry EM, Pasetti MF.

Clin Vaccine Immunol. 2017 Aug 4;24(8). pii: e00186-16. doi: 10.1128/CVI.00186-16. Print 2017 Aug.

4.

Blood glucose level prediction based on support vector regression using mobile platforms.

Reymann MP, Dorschky E, Groh BH, Martindale C, Blank P, Eskofier BM.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:2990-2993. doi: 10.1109/EMBC.2016.7591358.

PMID:
28268941
5.

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.

Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK, Wang X, Warfield KL, Aman MJ.

Clin Vaccine Immunol. 2016 Dec 5;23(12):918-925. Print 2016 Dec.

6.

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.

Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, Kassa T, Oot L, Sequeira J, Reymann M, Blackwelder WC, Wu Y, Ruslanova I, Goswami J, Sow SO, Pasetti MF, Steinglass R, Kebede A, Levine MM.

PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016.

7.

False-negative cerebrospinal fluid fungal culture results following oral antineoplastic therapy with a 5-fluorouracil derivative.

Judd WR, Shely RN, Ratliff PD, Reymann MT.

J Clin Pharm Ther. 2015 Dec;40(6):696-8. doi: 10.1111/jcpt.12326. Epub 2015 Oct 12.

PMID:
26456089
8.

Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey.

Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, Kassa T, Oot L, Sequeira J, Reymann M, Blackwelder WC, Pasetti MF, Sow SO, Steinglass R, Kebede A, Levine MM.

Am J Trop Med Hyg. 2015 Aug;93(2):416-424. doi: 10.4269/ajtmh.15-0198. Epub 2015 Jun 8.

9.

Dense energetic nitraminofurazanes.

Fischer D, Klapötke TM, Reymann M, Stierstorfer J.

Chemistry. 2014 May 19;20(21):6401-11. doi: 10.1002/chem.201400362. Epub 2014 Apr 15.

PMID:
24737545
10.

ED use by older adults attempting suicide.

Carter MW, Reymann MR.

Am J Emerg Med. 2014 Jun;32(6):535-40. doi: 10.1016/j.ajem.2014.02.003. Epub 2014 Feb 10.

PMID:
24630804
11.

Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR.

Muhsen K, Lagos R, Reymann MK, Graham DY, Pasetti MF, Levine MM.

PLoS One. 2014 Jan 15;9(1):e83999. doi: 10.1371/journal.pone.0083999. eCollection 2014.

12.

Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.

Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM.

J Infect Dis. 2014 May 1;209(9):1452-8. doi: 10.1093/infdis/jit625. Epub 2013 Nov 23.

13.

Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.

El-Kamary SS, Cohen MB, Bourgeois AL, Van De Verg L, Bauers N, Reymann M, Pasetti MF, Chen WH.

Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. doi: 10.1128/CVI.00464-13. Epub 2013 Sep 18. Erratum in: Clin Vaccine Immunol. 2014 Apr;21(4):602.

14.

Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy.

Barton JC, Coghlan ME, Reymann MT, Ozbirn TW, Acton RT.

Clin Infect Dis. 2003 Sep 1;37(5):e63-7. Epub 2003 Aug 12.

PMID:
12942420
15.

Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia.

Barton JC, Jones SC, Lamberth WC, Reymann MT, Scott VC.

Am J Hematol. 2002 Oct;71(2):139-40. No abstract available.

16.

Validation of a gastrointestinal explant system for measurement of mucosal antibody production.

Losonsky GA, Fantry GT, Reymann M, Lim Y.

Clin Diagn Lab Immunol. 1999 Nov;6(6):803-7.

17.

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

Galen JE, Gomez-Duarte OG, Losonsky GA, Halpern JL, Lauderbaugh CS, Kaintuck S, Reymann MK, Levine MM.

Vaccine. 1997 Apr-May;15(6-7):700-8.

PMID:
9178472
18.

Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.

Losonsky GA, Yunyongying J, Lim V, Reymann M, Lim YL, Wasserman SS, Levine MM.

Infect Immun. 1996 Jan;64(1):10-5.

19.

Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.

Levine MM, McEwen J, Losonsky G, Reymann M, Harari I, Brown JE, Taylor DN, Donohue-Rolfe A, Cohen D, Bennish M, et al.

J Clin Microbiol. 1992 Jul;30(7):1636-41.

20.

Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Tacket CO, Forrest B, Morona R, Attridge SR, LaBrooy J, Tall BD, Reymann M, Rowley D, Levine MM.

Infect Immun. 1990 Jun;58(6):1620-7.

21.
22.

Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease.

Reymann MT, Bradac JA, Cobbs CG, Dismukes WE.

Antimicrob Agents Chemother. 1979 Sep;16(3):353-61.

23.

Persistent bacteremia in staphylococcal endocarditis.

Reymann MT, Holley HP Jr, Cobbs CG.

Am J Med. 1978 Nov;65(5):729-37.

PMID:
707532

Supplemental Content

Loading ...
Support Center